Sanofi fronts €300M to partner up with Innovent on China market, eyeing quick pivot to commercialization - Endpoints News

Sanofi has found a high-profile partner in China to take two of its top cancer drug prospects through the clinic and onto the big Asian market. And they’re buying into the partner’s stock — at a significant premium — to make that happen. At the end of the day…

A federal appeals court on Tuesday denied prosecutors’ attempt to lengthen the sentences of two former GSK scientists who pleaded guilty to stealing trade secrets. Yu Xue and Tao Li pleaded guilty b… [+625 chars]

full article...